SLC30A8 and type 2 diabetes mellitus: In studies of the mechanisms by which altered ZnT8 activity influences T2D risk, the primary focus thus far has been on characterising metabolic phenotype—notably glucose-regulated insulin secretion—and there has been little investigation of the impact of LoF mutations on zinc homeostasis.